UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Celastrol Attenuates the Invasion and Migration and Augments the Anticancer Effects of Bortezomib in a Xenograft Mouse Model of Multiple Myeloma

Frontiers in pharmacology, 2018-05, Vol.9, p.365-365

2018

Volltextzugriff (PDF)

Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling

Cancer research (Chicago, Ill.), 2007-04, Vol.67 (7), p.2982-2989

2007

Volltextzugriff (PDF)

Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities

Modern pathology, 2012-05, Vol.25 (5), p.651-660

2012

Volltextzugriff (PDF)

Establishment of Adult Peripheral Blood Lymphocyte Subset Reference Range for an Asian Population by Single-Platform Flow Cytometry: Influence of Age, Sex, and Race and Comparison with Other Published Studies

Clinical and Diagnostic Laboratory Immunology, 2004-01, Vol.11 (1), p.168-173

2004

Volltextzugriff (PDF)

Centrosomes and myeloma; Aneuploidy and proliferation

Environmental and molecular mutagenesis, 2009-10, Vol.50 (8), p.697-707

2009

Volltextzugriff (PDF)

Clinical implication of centrosome amplification in plasma cell neoplasm

Blood, 2006-05, Vol.107 (9), p.3669-3675

2006

Volltextzugriff (PDF)

Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib

Blood, 2007-04, Vol.109 (8), p.3177-3188

2007

Volltextzugriff (PDF)

The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibition

Blood, 2008-02, Vol.111 (3), p.1603-1609

2008

Volltextzugriff (PDF)

Belinostat exerts antitumor cytotoxicity through the ubiquitin‐proteasome pathway in lung squamous cell carcinoma

Molecular oncology, 2017-08, Vol.11 (8), p.965-980

2017

Volltextzugriff (PDF)

“Micro”-managing the MiRNome in SzS

Blood, 2010-08, Vol.116 (7), p.1021-1022

Chng, Wee J.

2010

Volltextzugriff (PDF)

Gene-expression profiling of Waldenström macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma

Blood, 2006-10, Vol.108 (8), p.2755-2763

2006

Volltextzugriff (PDF)

Gene expression profiling of pulmonary mucosa-associated lymphoid tissue lymphoma identifies new biologic insights with potential diagnostic and therapeutic applications

Blood, 2009-01, Vol.113 (3), p.635-645

2009

Volltextzugriff (PDF)

MYC, BCL2 AND BCL6 COEXPRESSION PATTERNS AT SINGLE‐CELL RESOLUTION RE‐DEFINE DOUBLE EXPRESSOR LYMPHOMAS

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications

Blood, 2007-02, Vol.109 (3), p.1228-1232

2007

Volltextzugriff (PDF)

Analysis of genetic abnormalities provides insights into genetic evolution of hyperdiploid myeloma

Genes chromosomes & cancer, 2006-12, Vol.45 (12), p.1111-1120

2006

Volltextzugriff (PDF)

Cell lines of hyperdiploid myeloma, are we there yet?

British journal of haematology, 2008-03, Vol.140 (5), p.579-580

2008

Volltextzugriff (PDF)

Neurobeachin ( NBEA ) is a target of recurrent interstitial deletions at 13q13 in patients with MGUS and multiple myeloma

Experimental hematology, 2009-02, Vol.37 (2), p.234-244

2009

Volltextzugriff (PDF)

Survival of genetic subtypes of relapsed myeloma may be modulated by secondary events

Blood, 2007-04, Vol.109 (8), p.3610-3611

2007

Volltextzugriff (PDF)

Cytarabine syndrome revisited

British journal of haematology, 2003-09, Vol.122 (6), p.875-875

Chng, Wee J.

2003

Volltextzugriff (PDF)

The impact of frontline risk-adapted strategy on the overall survival of patients with newly diagnosed multiple myeloma: an analysis of the Singapore multiple myeloma study group

European journal of haematology, 2012-08, Vol.89 (2), p.136-144

2012

Volltextzugriff (PDF)

MicroRNA in Chronic Lymphocytic Leukemia

The New England journal of medicine, 2006-02, Vol.354 (5), p.524-525

2006

Volltextzugriff (PDF)

Cyclosporine treatment for patients with CRF who developed pure red blood cell aplasia following EPO therapy

American journal of kidney diseases, 2003-03, Vol.41 (3), p.692-695

2003

Volltextzugriff (PDF)

Genomics in multiple myeloma: biology and clinical implications

Pharmacogenomics, 2005-09, Vol.6 (6), p.563-573

2005

Volltextzugriff (PDF)

Late-onset marrow aplasia due to imatinib in newly diagnosed chronic phase chronic myeloid leukaemia

Leukemia research, 2005-06, Vol.29 (6), p.719-720

2005

Volltextzugriff (PDF)

1 – 25 von 199

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(192)
Mit Volltextzugriff
(183)

Publikationsform

Sprache

Englisch
(199)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(45)
Plos One
(9)
Leukemia
(8)
The New England Journal Of Medicine
(7)
Cancer Research
(5)
British Journal Of Haematology
(4)
Cancer Cell
(4)
Clinical Lymphoma, Myeloma And Leukemia
(4)
The Lancet Oncology
(4)
Blood Cancer Journal
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Celastrol Attenuates the Invasion and Migration and Augments the Anticancer Effects of Bortezomib in a Xenograft Mouse Model of Multiple Myeloma

Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling

Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities

Variation in immunoglobulin use and impact on survival in myeloma

Establishment of Adult Peripheral Blood Lymphocyte Subset Reference Range for an Asian Population by Single-Platform Flow Cytometry: Influence of Age, Sex, and Race and Comparison with Other Published Studies

Centrosomes and myeloma; Aneuploidy and proliferation

Clinical implication of centrosome amplification in plasma cell neoplasm

Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib

The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibition

Belinostat exerts antitumor cytotoxicity through the ubiquitin‐proteasome pathway in lung squamous cell carcinoma

“Micro”-managing the MiRNome in SzS

Gene-expression profiling of Waldenström macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma

Gene expression profiling of pulmonary mucosa-associated lymphoid tissue lymphoma identifies new biologic insights with potential diagnostic and therapeutic applications

MYC, BCL2 AND BCL6 COEXPRESSION PATTERNS AT SINGLE‐CELL RESOLUTION RE‐DEFINE DOUBLE EXPRESSOR LYMPHOMAS

Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications

Analysis of genetic abnormalities provides insights into genetic evolution of hyperdiploid myeloma

Cell lines of hyperdiploid myeloma, are we there yet?

Neurobeachin ( NBEA ) is a target of recurrent interstitial deletions at 13q13 in patients with MGUS and multiple myeloma

Survival of genetic subtypes of relapsed myeloma may be modulated by secondary events

Cytarabine syndrome revisited

The impact of frontline risk-adapted strategy on the overall survival of patients with newly diagnosed multiple myeloma: an analysis of the Singapore multiple myeloma study group

MicroRNA in Chronic Lymphocytic Leukemia

Cyclosporine treatment for patients with CRF who developed pure red blood cell aplasia following EPO therapy

Genomics in multiple myeloma: biology and clinical implications

Late-onset marrow aplasia due to imatinib in newly diagnosed chronic phase chronic myeloid leukaemia

Suchergebnisse filtern